To minimize all injection site reactions, patients should ensure proper injection technique, rotate sites consistently, maintain good skin hygiene, and use each needle only once as directed
Month 6-12 (2.4 mg maintenance): Weight loss continues but gradually slows
For example, the safety of GLP-1 agonists during pregnancy remains unclear
2023;46:S14057
These can include nausea, vomiting, diarrhea, constipation, abdominal discomfort, reflux, and reduced appetite
If pancreatitis is suspected, discontinue Ozempic or Rybelsus tablets and initiate appropriate management Diabetic Retinopathy Complications: In a pooled analysis of glycemic control trials, patients reported diabetic retinopathy related adverse reactions during the trial (4.2% with semaglutide tablets and 3.8% with comparator)